Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients

Hemodialysis International

Volumn 16, Issue 4, 2012, Pages 465-472

  Velasco, Nestor ^a   Chamney, Paul ^b   Wabel, Peter ^b   Moissl, Ulrich ^b   Imtiaz, Toufeeq ^a   Spalding, Elaine ^a   Mcgregor, Mark ^a   Innes, Andrew ^a   Mackay, Ian ^a   Patel, Rajan ^c   Jardine, Alan ^c  

^a NHS AYRSHIRE AND ARRAN   (United Kingdom)

^b FRESENIUS MEDICAL CARE   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cardiac troponin; Cardiovascular risk; Fluid overload; Left ventricular hypertrophy; Markers; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; TROPONIN T;

ADULT; AGED; ARTICLE; BIOIMPEDANCE SPECTROSCOPY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHRONIC FLUID OVERLOAD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUID INTAKE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HUMAN; HYPERVOLEMIA; LEFT VENTRICULAR MASS INDEX; MALE; MONITORING; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SPECTROSCOPY;

AGED; BIOLOGICAL MARKERS; BODY FLUIDS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIELECTRIC SPECTROSCOPY; FEMALE; HEMODIAFILTRATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RENAL DIALYSIS; RISK FACTORS; TROPONIN;

EID: 84867096563     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2012.00689.x     Document Type: Article

References (59)

1. Ritz E, Wanner C. The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol. 2008; 3:920-929.
2. DeFilippi CR, Christenson RH. B-type natriuretic peptide (BNP)/NT-proBNP and renal function: Is the controversy over? Clin Chem. 2009; 55:1271-1273.
3. Srisawasdi P, Vanavanan S, Charoenpanichkit C, Kroll MH. The effect of renal dysfunction on BNP, NT-proBNP, and their ratio. Am J Clin Pathol. 2010; 133:14-23.
4. Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007; 50:1009-1019.
5. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int. 2007; 71:548-554.
6. Zoccali C, Mallamaci F, Benedetto FA, etal. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001; 12:1508-1515.
7. Mark PB, Stewart GA, Gansevoort RT, etal. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant. 2006; 21:402-410.
8. Hamwi SM, Sharma AK, Weissman NJ, etal. Troponin-I elevation in patients with increased left ventricular mass. Am J Cardiol. 2003; 92:88-90.
9. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002; 106:2941-2945.
10. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis. Circulation. 2005; 112:3088-3096.
11. Hickson LJ, Cosio FG, El-Zoghby ZM, etal. Survival of patients on the kidney transplant wait list: Relationship to cardiac troponin T. Am J Transplant. 2008; 8:2352-2359.
12. Sommerer C, Beimler J, Schwenger V, etal. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest. 2007; 37:350-356.
13. Hickman PE, McGill DA, Talaulikar G, etal. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J. 2008; 39:812-818.
14. Choi SY, Lee JE, Jang EH, etal. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients. Nephron Clin Pract. 2008; 110:c93-100.
15. Ifudu O. The concept of "dry weight" in maintenance hemodialysis: Flaws in clinical application. Int J Artif Organs. 1996; 19:384-386.
16. Charra B, Calemard M, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol. 1996; 16:35-44.
17. Jacobs LH, van de Kerkhof JJ, Mingels AM, etal. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: A longitudinal study. Nephrol Dial Transplant. 2010; 25:243-248.
18. Ortega O, Rodriguez I, Gracia C, etal. Strict volume control and longitudinal changes in cardiac biomarker levels in hemodialysis patients. Nephron Clin Pract. 2009; 113:c96-103.
19. David S, Kumpers P, Seidler V, Biertz F, Haller H, Fliser D. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. Nephrol Dial Transplant. 2008; 23:1370-1377.
20. Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol. 2008; 102:469-474.
21. Bargnoux AS, Klouche K, Fareh J, etal. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration. Clin Chem Lab Med. 2008; 46:1019-1024.
22. Basile C, Vernaglione L, Di IB, etal. Development and validation of bioimpedance analysis prediction equations for dry weight in hemodialysis patients. Clin J Am Soc Nephrol. 2007; 2:675-680.
23. Raimann J, Liu L, Ulloa D, Kotanko P, Levin NW. Consequences of overhydration and the need for dry weight assessment. Contrib Nephrol. 2008; 161:99-107.
24. Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes is dialysis patients. Kidney Int. 2006; 69:1609-1620.
25. Chamney PW, Wabel P, Moissl UM, etal. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr. 2007; 85:80-89.
26. Wizemann V, Wabel P, Chamney P, etal. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009; 24:1574-1579.
27. Machek P, Jirka T, Moissl U, Chamney P, Wabel P. Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant. 2010; 25:538-544.
28. Chazot C. Managing dry weight and hypertension in dialysis patients: Still a challenge for the nephrologist in 2009? J Nephrol. 2009; 22:587-597.
29. Gunal AI, Karaca I, Aygen B, Yavuzkir M, Dogukan A, Celiker H. Strict fluid volume control and left ventricular hypertrophy in hypertensive patients on chronic haemodialysis: A cross-sectional study. J Int Med Res. 2004; 32:70-77.
30. Charra B, Calemard E, Ruffet M, etal. Survival as an index of adequacy of dialysis. Kidney Int. 1992; 41:1286-1291.
31. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol. 2000; 11:912-916.
32. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002; 61:2235-2239.
33. Goldfarb-Rumyantzev AS, Chelamcharla M, Bray BE, etal. Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis. Nephron Clin Pract. 2009; 113:c270-c280.
34. Ozkahya M, Ok E, Toz H, etal. Long survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant. 2006; 21:1-8.
35. Charra B. Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int. 2007; 11:21-31.
36. Suri RS, Nesrallah GE, Mainra R, etal. Daily hemodialysis: A systematic review. Clin J Am Soc Nephrol. 2006; 1:33-42.
37. Walsh M, Culleton B, Tonelli M, Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int. 2005; 67:1500-1508.
38. Chertow GM, Levin NW, Beck GJ, etal. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363:2287-2300.
39. Zucchelli P, Santoro A. Dry weight in hemodialysis: Volemic control. Semin Nephrol. 2001; 21:286-290.
40. Velasco N. Convection with conviction-online hemodiafiltration for all: Single center clinical observations. Hemodial Int. 2006; 10(Suppl 1):S67-S71.
41. Spalding EM, Velasco N. Dialysis hypotension: Don't blame the targets. Kidney Int. 2008; 74:1624-1625.
42. Kalantar-Zadeh K, Regidor DL, Kovesdy CP, etal. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009; 119:671-679.
43. Moissl UM, Wabel P, Chamney PW, etal. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006; 27:921-933.
44. Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif. 2009; 27:75-80.
45. Wabel P, Moissl U, Chamney P, etal. Towards improved cardiovascular management: The necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008; 23:2965-2971.
46. Stewart GA, Mark PB, Johnston N, etal. Determinants of hypertension and left ventricular function in end stage renal failure: A pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging. 2004; 24:387-393.
47. Patel RK, Oliver S, Mark PB, etal. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol. 2009; 4:1477-1483.
48. Fagugli RM, Ricciardi D, Rossi D, De GA, Taglioni C. Blood pressure assessment in haemodialysis patients: Comparison between pre-dialysis blood pressure and ambulatory blood pressure measurement. Nephrology (Carlton). 2009; 14:283-290.
49. Covic A, Goldsmith DJ, Covic M. Reduced blood pressure diurnal variability as a risk factor for progressive left ventricular dilatation in hemodialysis patients. Am J Kidney Dis. 2000; 35:617-623.
50. Liu M, Takahashi H, Morita Y, etal. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant. 2003; 18:563-569.
51. Fagugli RM, Reboldi G, Quintaliani G, etal. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001; 38:371-376.
52. Hampl H, Sternberg C, Berweck S, etal. Regression of left ventricular hypertrophy in hemodialysis patients is possible. Clin Nephrol. 2002; 58(Suppl 1):S73-S96.
53. O'Connor CM, Abraham WT, Albert NM, etal. Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008; 156:662-673.
54. Abraham WT, Fonarow GC, Albert NM, etal. Predictors of in-hospital mortality in patients hospitalized for heart failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol. 2008; 52:347-356.
55. Fagugli RM, Pasini P, Pasticci F, Ciao G, Cicconi B, Buoncristiani U. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: A comparative study. J Nephrol. 2006; 19:77-83.
56. DeFilippi CR, Fink JC, Nass CM, Chen H, Christenson R. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis. 2005; 46:35-44.
57. Myerson SG, Bellenger NG, Pennell DJ. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension. 2002; 39:750-755.
58. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006; 92:843-849.
59. Flythe JE, Kimmel SE, Brunelli SM. Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int. 2011; 79:250-257.